全球 MRI 造影剂市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

全球 MRI 造影剂市场需求预计将从 2022 年的 29.8 亿美元达到 2030 年近 55.8 亿美元的市场规模，2023-2030 年研究期间复合年增长率为 8.15%。

MRI（磁共振成像）造影剂，也称为造影剂，是 MRI 过程中使用的物质，用于增强体内特定组织和结构的可见度。将造影剂引入体内，在不同组织之间产生更强的对比度，有助于某些区域的可视化并提高 MRI 的诊断准确性。

市场动态：

由于对精确诊断成像的需求、技术进步以及需要成像的医疗状况的日益普遍等因素，MRI 造影剂市场正在扩大。造影剂可增强 MRI 扫描期间特定组织的可见度，从而实现准确的诊断并改进治疗计划。对非侵入性成像程序不断增长的需求以及将对比增强 MRI 纳入临床指南推动了市场增长。技术创新有助于提高图像质量、安全性和患者治疗效果。人口老龄化和慢性病发病率的上升需要频繁的成像，进一步刺激了对造影剂的需求。正在进行的研究重点是开发更安全、更有效的药物，以解决安全问题并改善患者的治疗结果。随着医疗保健提供者优先考虑准确的成像和以患者为中心的护理，MRI 扫描中造影剂的使用有望扩大，特别是在医疗保健基础设施不断发展的新兴市场。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球核磁共振造影剂市场的各个细分市场进行了包容性评估。核磁共振造影剂行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲 MRI 造影剂市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 MRI 造影剂市场的主要参与者包括 GE Healthcare、Bayer AG、Guerbet GmbH、Bracco Imaging Spa、Vitalquan, LLC、Miltenyi Biotec BV & Co. Kg。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市场亮点
• 全球市场概况

第 3 章：MRI 造影剂 - 行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 行业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 按类型分類的市场吸引力分析
  • 市场吸引力分析：按应用分类
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原料厂商清单
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直效行销
  • 间接营销
  • 营销渠道发展趋势

第 5 章：全球 MRI 造影剂市场分析：按产品分类

• 按产品概述
• 历史和预测数据
• 按产品分析
• 顺磁剂
• 超顺磁剂

第 6 章：全球 MRI 造影剂市场分析：按类型

• 按类型概述
• 历史和预测数据
• 按类型分析
• 临床
• 临床前

第 7 章：全球 MRI 造影剂市场分析：按应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 胃肠道
• 静脉
• 肝胆
• 神经影像
• 其他的

第 8 章：全球 MRI 造影剂市场分析：按最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 医院
• 影像中心

第 9 章：全球 MRI 造影剂市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史和预测数据销售分析
  • 北美按细分市场销售分析
  • 北美按国家/地区销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史和预测数据销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家/地区销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史和预测数据销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史和预测数据销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家/地区销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史和预测数据销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 10 章：MRI 造影剂代理商公司的竞争格局

• Mri 对比介质代理市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 公司股份分析
• 市场集中度
• GE Healthcare
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bayer AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Guerbet GmbH
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bracco Imaging Spa
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Vitalquan LLC
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Miltenyi Biotec BV & Co. Kg
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

The global demand for MRI Contrast Media Agents Market is presumed to reach the market size of nearly USD 5.58 BN by 2030 from USD 2.98 BN in 2022 with a CAGR of 8.15% under the study period 2023 - 2030.

MRI (Magnetic Resonance Imaging) contrast media agents, also known as contrast agents, are substances used during MRI procedures to enhance the visibility of specific tissues and structures within the body. Contrast media agents are introduced into the body to create a stronger contrast between different tissues, aiding in the visualization of certain areas and improving the diagnostic accuracy of the MRI.

MARKET DYNAMICS:

The MRI Contrast Media Agents market is expanding due to factors such as the demand for precise diagnostic imaging, technological advancements, and the increasing prevalence of medical conditions requiring imaging. Contrast media agents enhance the visibility of specific tissues during MRI scans, leading to accurate diagnoses and improved treatment planning. The rising demand for non-invasive imaging procedures and the incorporation of contrast-enhanced MRI in clinical guidelines drive market growth. Technological innovations contribute to improved image quality, safety, and patient outcomes. The ageing population and the higher incidence of chronic diseases necessitate frequent imaging, further fueling the demand for contrast media agents. Ongoing research focuses on developing safer and more efficient agents to address safety concerns and improve patient outcomes. As healthcare providers prioritize accurate imaging and patient-centric care, the utilization of contrast media agents in MRI scans is poised to expand, particularly in emerging markets with growing healthcare infrastructure.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mri contrast media agents. The growth and trends of mri contrast media agents industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the mri contrast media agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Paramagnetic Agents
• Superparamagnetic Agents

By Type

• Clinical
• Preclinical

By Application

• Gastrointestinal
• Intravenous
• Hepatobiliary
• Neurological Imaging
• Others

By End-Use

• Hospitals
• Imaging Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the MRI Contrast Media Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the MRI Contrast Media Agents market include GE Healthcare, Bayer AG, Guerbet GmbH, Bracco Imaging Spa, Vitalquan, LLC, Miltenyi Biotec B.V. & Co. Kg. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . MRI CONTRAST MEDIA AGENTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Type
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End-use
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Paramagnetic Agents Historic and Forecast Sales by Regions
• 5.5 Superparamagnetic Agents Historic and Forecast Sales by Regions

6 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY TYPE

• 6.1 Overview by Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Type
• 6.4 Clinical Historic and Forecast Sales by Regions
• 6.5 Preclinical Historic and Forecast Sales by Regions

7 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Gastrointestinal Historic and Forecast Sales by Regions
• 7.5 Intravenous Historic and Forecast Sales by Regions
• 7.6 Hepatobiliary Historic and Forecast Sales by Regions
• 7.7 Neurological Imaging Historic and Forecast Sales by Regions
• 7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY END-USE

• 8.1 Overview by End-use
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-use
• 8.4 Hospitals Historic and Forecast Sales by Regions
• 8.5 Imaging Centers Historic and Forecast Sales by Regions

9 . GLOBAL MRI CONTRAST MEDIA AGENTS MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE MRI CONTRAST MEDIA AGENTS COMPANIES

• 10.1. Mri Contrast Media Agents Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF MRI CONTRAST MEDIA AGENTS INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. GE Healthcare
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Bayer AG
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Guerbet GmbH
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Bracco Imaging Spa
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Vitalquan LLC
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Miltenyi Biotec B.V. & Co. Kg
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Paramagnetic Agents Market Sales by Geography (USD MN)
• Superparamagnetic Agents Market Sales by Geography (USD MN)
• Analysis Market by Type (USD MN)
• Clinical Market Sales by Geography (USD MN)
• Preclinical Market Sales by Geography (USD MN)
• Analysis by Application (USD MN)
• Gastrointestinal Market Sales by Geography (USD MN)
• Intravenous Market Sales by Geography (USD MN)
• Hepatobiliary Market Sales by Geography (USD MN)
• Neurological Imaging Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Imaging Centers Market Sales by Geography (USD MN)
• Global Mri Contrast Media Agents Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Mri Contrast Media Agents Report
• Market Research Process
• Market Research Methodology
• Global Mri Contrast Media Agents Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Paramagnetic Agents Market Sales by Geography (USD MN)
• Superparamagnetic Agents Market Sales by Geography (USD MN)
• Global Market Analysis by Type (USD MN)
• Clinical Market Sales by Geography (USD MN)
• Preclinical Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Gastrointestinal Market Sales by Geography (USD MN)
• Intravenous Market Sales by Geography (USD MN)
• Hepatobiliary Market Sales by Geography (USD MN)
• Neurological Imaging Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Imaging Centers Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.